We hypothesize that ENO1 may contribute to tumor progression via the PI3K/Akt pathway mediating the activity of Cyclin D1, Cyclin E, and NF-κB, which will eventually result in hyperphosphorylation of Rb and downregulation of E-cadherin mediated classical EMT. The gene discussed is CCND1; the disease is neoplasm.